
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster eventually faces competition– here's what Lilly is doing to avoid the boom-and-bust cycle that has humbled pharma giants in the past. (Source: Bloomberg)
View original source — Bloomberg ↗


